Metoprolol Succinate NDC 68788-8312

Product information

Brand name (proprietary)

Metoprolol Succinate

Generic name (nonproprietary)

metoprolol succinate

Active ingredients

Metoprolol succinate — 50 mg/1

Dosage form

Tablet, Extended release

Route

Oral

Labeler

Preferred Pharmaceuticals Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 207465

Marketing start

Dec 20, 2022

Listing expires

Dec 31, 2027

Other FDA classes

Adrenergic beta-Antagonists (Mechanism)

Identifiers

Product ID 68788-8312_cbe0e043-d578-4a7f-9b88-68569f300b1dSPL ID cbe0e043-d578-4a7f-9b88-68569f300b1dSPL set ID 7dfe56fe-68b6-4897-9238-0f530c92e27eRxCUI 866436UNII TH25PD4CCB

Pharmacologic class

beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788831201 followed by a unit qualifier and the quantity Copy

Package 68788-8312-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 207465

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.